Introduction to Inogla Tablet
Inogla Tablet, containing the active ingredient Teneligliptin (20mg), is a prescription medication used in the treatment of Type 2 diabetes mellitus. Manufactured by Wockhardt Ltd, each strip contains 15 tablets. The MRP for a strip is ₹217.5. Teneligliptin belongs to the chemical class of Alpha amino acid amides and falls under the therapeutic class of ANTI DIABETIC drugs. It functions as a DPP-4 inhibitor and is not habit-forming.
Uses of Inogla Tablet
Inogla Tablet is primarily indicated for managing Type 2 diabetes mellitus. It helps control blood sugar levels by increasing the release of insulin and inhibiting the production of glucagon.
Dosage and Administration
It is crucial to take Inogla Tablet exactly as prescribed by your healthcare provider. The usual recommended dose is one tablet daily, to be taken orally with or without food. It is essential to swallow the tablet whole, without chewing, crushing, or breaking it. To ensure the most benefit, take the medication at the same time each day.
Benefits of Inogla Tablet
Inogla Tablet offers several benefits in the management of Type 2 diabetes mellitus. By regulating blood sugar levels, it helps reduce the risk of complications associated with diabetes, such as nerve damage, kidney problems, and vision issues.
Side Effects of Inogla Tablet
While generally well-tolerated, Inogla Tablet may cause some side effects. The most common side effects include hypoglycemia (low blood glucose levels) and constipation. It is essential to consult your healthcare provider if you experience any adverse effects while taking this medication.
Active Ingredients in Inogla Tablet
The active ingredient in Inogla Tablet is Teneligliptin, which belongs to the class of DPP-4 inhibitors. Teneligliptin works by increasing insulin secretion and decreasing glucagon production, leading to improved blood sugar control in patients with Type 2 diabetes mellitus.
Pharmacological Properties of Inogla Tablet
Teneligliptin, the active ingredient in Inogla Tablet, exhibits potent inhibitory activity against DPP-4 enzymes. By inhibiting DPP-4, it prolongs the action of incretin hormones, which stimulate insulin secretion and inhibit glucagon release. This mechanism helps regulate blood glucose levels in diabetic patients.
Indications for Inogla Tablet
Inogla Tablet is indicated for the management of Type 2 diabetes mellitus. It is prescribed to individuals to help control their blood sugar levels and reduce the risk of diabetic complications.
Contraindications of Inogla Tablet
Inogla Tablet is contraindicated in patients with a known allergy to Teneligliptin or any other components of the formulation. It should not be used in individuals with Type 1 diabetes, diabetic ketoacidosis, or severe renal impairment.
Drug Interactions
Inogla Tablet may interact with certain medications, altering their effects or increasing the risk of side effects. It is essential to inform your healthcare provider about all the medications, supplements, or herbal products you are taking before starting Inogla Tablet to avoid potential drug interactions.
Patient Counseling
Patients taking Inogla Tablet should be counseled on the importance of adherence to the prescribed dosage regimen. They should monitor their blood sugar levels regularly and report any unusual symptoms or side effects to their healthcare provider. Lifestyle modifications, such as a healthy diet and regular exercise, should be incorporated to improve treatment outcomes.
Clinical Evidence
Clinical studies have demonstrated the efficacy of Teneligliptin, the active ingredient in Inogla Tablet, in managing Type 2 diabetes mellitus. These studies have shown significant improvements in blood glucose control and a reduced risk of diabetic complications in patients treated with Teneligliptin.
Frequently Asked Questions (FAQs)
Q: Is Inogla Tablet habit-forming?
A: No, Inogla Tablet is not habit-forming. It does not lead to dependence or addiction.
Q: Can I take Inogla Tablet with other diabetes medications?
A: Inogla Tablet may interact with other diabetes medications. It is essential to consult your healthcare provider before combining it with other drugs to avoid potential interactions.
Q: What should I do if I miss a dose of Inogla Tablet?
A: If you miss a dose of Inogla Tablet, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to make up for the missed one.
Q: Are there any special precautions to be followed while taking Inogla Tablet?
A: Patients taking Inogla Tablet should monitor their blood sugar levels regularly, especially during illness or changes in medication. It is crucial to follow a healthy diet, exercise regularly, and avoid excessive alcohol consumption while on this medication.
Q: How long does it take for Inogla Tablet to show results?
A: The onset of action of Inogla Tablet may vary from person to person. It is essential to continue taking the medication as prescribed by your healthcare provider to achieve the desired effects on blood glucose control.
Incorporating the detailed information provided above will help enhance the content on the Inogla Tablet page of your website, making it more informative and engaging for visitors seeking information about this medication.
MRP:
₹217.5
Manufacturer:
Wockhardt Ltd
Salt:
Teneligliptin (20mg),
How to UseInogla Tablet:
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Inogla Tablet may be taken with or without food, but it is better to take it at a fixed time.
Side Effects of Inogla Tablet:
Hypoglycemia (low blood glucose level),Constipation,
Alternate Medicines for Inogla Tablet:
Tenlimac Tablet,Dynaglipt Tablet,Megagliptin Tablet,Tenali Tablet,Tenligress 20mg Tablet,
Prescription Required Status:
Prescription Required
Type of Selection:
15 tablets in 1 strip
Chemical Class:
Alpha amino acid amides
Habit Forming:
No
Therapeutic Class:
ANTI DIABETIC
Action Class:
DPP-4 inhibitors
. Please note, this information is for educational purposes only and not intended as medical advice.
